NVIC Commentary · Pregnancy

Vaccination During Pregnancy – Is It Safe?

By Barbara Loe Fisher · Published October 31, 2026 · 17 min read

In 1977, when I found out I was going to become a Mom, I instinctively knew I needed to be careful, especially during the first two trimesters when a pregnant woman’s body undergoes profound changes1 and the major organ systems of the fetus develop at a rapid rate.23

When I was in college in the late 1960s, I had heard about Thalidomide, a drug prescribed for women with morning sickness in the first trimester of pregnancy, and whose babies died or were born without arms or legs.4 What happened to those babies because their mothers took a prescription drug during pregnancy, a drug that doctors assumed was safe for pregnant women, was a warning. I knew it was up to me to do everything I could to protect my health and the health of my baby both before and after he was born.

Mothers-to-be having babies in the 1970s and 80s were told to take extra vitamins and eat nutritious food but, most of all, to avoid putting anything into our bodies or exposing ourselves to environmental toxins that could potentially harm the developing fetus – like alcohol, cigarette smoke, certain medications, radiation, household cleaning products and other toxic exposures.

Some of us were aware of the risks to mother and infant of being heavily anesthetized during labor and delivery and I signed up for Lamaze classes to prepare for a drug-free birth,5 which many obstetricians strongly discouraged. After going to the library and reading books on care of newborns, I chose to breastfeed to give my baby maternal antibodies and natural protection against infections,6 even though in the 1970s a lot of pediatricians were still pushing formula and bottle feeding as a more guaranteed way to properly nourish infants after birth.7

Today, pregnant women face a different set of difficult questions and choices about keeping themselves and their babies healthy during a time when pregnancy brings about profound changes in a woman’s body and the baby growing in the womb is undergoing profound changes, too.891011

Among the choices pregnant women face are whether or not to get vaccinated during pregnancy, which public health officials, obstetricians and pediatricians maintain is absolutely necessary to safely and effectively protect pregnant women and newborns from seven infectious diseases – influenza, tetanus, diphtheria, pertussis, hepatitis B, COVID-19, and RSV.1213

01

Influenza and Tdap Vaccines: Recommended for All Pregnant Women Without the Data and Assumption of Safety

Vaccinating pregnant women is a relatively new medical policy, becoming a routine recommendation 20 years ago when, in 2006, the U.S. Centers for Disease Control and Prevention – the CDC – told all women – healthy or not – to get a flu shot during any trimester of each pregnancy to prevent influenza.14 Since the 1970’s, public health officials had recommended influenza vaccine for high risk women in the second or third trimester of pregnancy but, until 2006, few obstetricians promoted routine vaccination of healthy pregnant women.

Five years later, in 2011, the CDC recommended that women – healthy or not – who had never gotten a Tdap shot – a combination shot containing vaccines for tetanus, diphtheria and acellular pertussis vaccines – to get that shot in the second trimester of pregnancy, preferably after 20 weeks.15 Two years later, in 2013, the policy was expanded to administering a Tdap shot to all pregnant women during every pregnancy with the goal of not only preventing B. pertussis whooping cough infection in a pregnant woman, but also to transferring vaccine strain B. pertussis antibodies to the fetus to protect every newborn after birth until the first dose of DTaP vaccine is given at two months old.16

The CDC’s routine maternal vaccination recommendation that was instituted in 2006, 2011 and 2013 was endorsed by the American College of Obstetricians and Gynecologists (ACOG),17 the American Academy of Pediatrics (AAP) and other medical trade associations to encourage every doctor in the U.S. to adopt maternal vaccination as standard of care for all pregnant women.1819

With these maternal vaccination recommendations, the time-honored rule of avoiding any potential toxic exposure that might interfere with the normal development of the fetus was suspended and replaced with an assumption that vaccination during pregnancy is both necessary and safe.

But did the scientific evidence validate the assumption that giving influenza and Tdap vaccines to every pregnant woman was a rational one?

You have to look no further than information published in the vaccine manufacturer product inserts and posted online by the U.S. Food and Drug Administration (FDA) and Centers for Disease Control (CDC) to answer that question.2021

When the influenza and Tdap vaccines were licensed in the U.S., there was almost no scientific data on potential adverse biological responses like vaccine induced inflammatory responses,22 which could negatively affect pregnancy and birth outcomes and lead to miscarriage, birth defects, developmental delays or maternal and infant mortality. Pregnant women were not included in pre-licensure clinical trials testing the safety and efficacy of the influenza and Tdap vaccines.232425

At the time, the vaccines were categorized in either Pregnancy Category B, which meant that “no adequate and well controlled studies in pregnant women” had been conducted to demonstrate safety; or Pregnancy category C, which meant that “animal reproduction studies have shown an adverse effect on the fetus” but that “no adequate and well controlled studies in humans” had been conducted, with the FDA adding the caveat that “potential benefits may warrant use of the drug in pregnant women despite potential risks.”26

The assumption then – and the assumption today – is that vaccination during pregnancy is necessary, safe and effective and more is better even though significant knowledge gaps remain.272829

In current manufacturer product information inserts, drug companies marketing influenza and Tdap vaccines still state that the vaccines have “not been evaluated for carcinogenic or mutagenic potential, or impairment of male fertility.” For the Fluzone Quadrivalent vaccine, the manufacturer adds this warning about lack of safety data regarding poor health outcomes in infants born to women vaccinated during pregnancy: “Available data with Fluzone Quadrivalent use in pregnant women are insufficient to inform vaccine-associated risk of adverse developmental outcomes.”3031323334

Often the Tdap and influenza vaccines are given simultaneously on the same day to a pregnant woman. The toxicity of the vaccines’ ingredients,35 especially the synergistic effect of injecting all of them simultaneously into a pregnant woman has not been fully tested for potential genotoxic and other biological adverse effects on the mother or fetus that could negatively affect the development of her baby in the womb or the baby’s health after birth.363738

There are bioactive aluminum containing adjuvants in Tdap vaccines39 that stimulate a strong inflammatory response and also mercury containing Thimerosal preservatives40 in some multi-dose influenza vaccines. Other potentially toxic ingredients present in either Tdap or influenza vaccines include formaldehyde,4142 glutaraldehyde,43 phenoxyethanol,44 polysorbate 80,4546 octoxinol, also known as TRITONX-100,47 hydrocortisone,48 antibiotics,4950 and MDCK cell protein from dog kidneys.51

There are no published biological mechanism studies that assess pre-vaccination health of the mother-to-be and then measure pathological changes in brain and immune function, as well as DNA integrity, after a woman has been injected with vaccines during pregnancy – or what kinds of pathological and genetic changes have occurred in the baby developing in the womb and after birth.525354

After licensure of influenza and Tdap vaccines in the US, there were few studies available to demonstrate safety55 and effectiveness,56 and no well-designed prospective case-controlled studies conducted comparing maternal health and birth outcomes in large groups of women who got the vaccines during pregnancy – either separately or simultaneously – compared to those who did not get any vaccines during pregnancy. Studies and reviews were either small,57 retrospective,58 compared vaccinated women to vaccinated women,59 or were performed by drug company or government health officials using unpublished data.60 Also, there is a need for high-quality studies comparing the health of babies born to women vaccinated during pregnancy and those who remain unvaccinated to measure for all morbidity and mortality outcomes of newborns at birth and in the first year of life.

Injuries and deaths from pertussis-containing vaccines and influenza vaccines are the most compensated claims in the federal Vaccine Injury Compensation Program (VICP), which was established under the 1986 National Childhood Vaccine Injury Act.61 A 2013 study evaluating vaccine adverse event reports to the U.S. Vaccine Adverse Events Reporting System (VAERS) and to a European vaccine reaction reporting system found that reports of brain inflammation – acute disseminated encephalomyelitis (ADEM) – was the most frequently suspected cause of brain inflammation after influenza vaccination of adults over 18 years old, representing 32% of the total vaccine reaction cases reported. Pertussis containing DTaP vaccine was among the vaccines most frequently associated with reports of brain inflammation in children between birth and age five.62

If a pregnant woman is harmed by an influenza or Tdap vaccine, drug companies selling the vaccines in the U.S. and doctors or other vaccine providers are shielded from vaccine injury lawsuits. It is unclear whether vaccine injuries sustained by an unborn child in the womb will ever qualify for federal vaccine injury compensation in light of continuing scientific knowledge gaps.63

In addition to lack of credible scientific evidence to demonstrate safety, where is the evidence to demonstrate that it is effective or necessary for every pregnant woman to get an influenza and Tdap shot during every pregnancy?

The influenza vaccine has a poor track record of preventing influenza. Over the past two decades, the flu shot has been measured to be less than 50 percent effective in preventing Type A or B influenza in 16 out of the past 21 flu seasons.64 It is common knowledge that pertussis containing vaccines do not reliably prevent infection and transmission of B. pertussis whooping cough and there are many undiagnosed cases of whooping cough in vaccinated children and adults, who may show no or few symptoms, but still can transmit the infection to others.65666768

Two decades ago, it is fair to ask if the rush to vaccinate pregnant women and reach into the womb to try to passively vaccinate the developing fetus represents a case of policy preceding science.

The assumption in 2006 that vaccination during pregnancy is necessary, safe and effective paved the way for three more pharmaceutical products labeled “vaccines” to be added to the routine maternal vaccination schedule 15 years later.

02

COVID-19 Shots Recommended During Any Trimester of Pregnancy – Again Putting Policy Before the Science

In early 2020, a mutated coronavirus – SARS-CoV-2 – suddenly emerged out of a biohazard lab in China causing a respiratory infection called COVID-19 that turned into a global pandemic. In response, federal health agencies and the pharmaceutical companies Pfizer and Moderna fast tracked an experimental messenger RNA (mRNA) biological product to market by the end of 2020.6970 The product was labeled a vaccine and authorized by the FDA under a first-time Emergency Use Authorization (EUA) for distribution to the public.71

This meant that the normal pre-licensure animal toxicity studies and large clinical trials were not conducted to meet long standing safety and efficacy standards for licensing new vaccines.72 On top of that, the public was led to believe the COVID shot would prevent infection and transmission of the SARS-CoV-2 virus.7374 They were not adequately informed that the COVID biological, unlike traditional vaccines, was never designed to prevent infection or the ability to infect others, only to lessen severe symptoms of COVID disease and reduce hospitalizations and deaths.75

Pregnant and breast-feeding women have historically been excluded from vaccine clinical trials pre-licensure and they were explicitly excluded from most COVID-19 vaccine and treatment trials.76 In June 2021, CDC officials admitted there was “limited” safety data but expressed the “belief” it was “unlikely” it would harm pregnant women, stating, “Based on how these [COVID] vaccines work in the body, experts believe they are unlikely to pose a risk for people who are pregnant. However, there are currently limited data on the safety of COVID-19 vaccines in pregnant people.”77

Two months later, in August 2021, the CDC issued a press release stating that, based on new data from internal COVID shot monitoring systems, the shot is safe and effective for pregnant women. Federal health officials said that every woman who was pregnant could and should get the COVID shot during any trimester of pregnancy.78

Although several non-mNRA COVID vaccines were made available, it was the Pfizer and Moderna mRNA products that dominated the market79 and were the COVID shots most doctors in the U.S. gave pregnant women to comply with the CDC’s universal use recommendation that every man, woman and child in the U.S. should be injected with COVID shots.80

In the U.S., what started out as a federal vaccine recommendation morphed into a federal mandate for millions of Americans81 – including pregnant women working in certain professions – to get the first mRNA product using a lipid nanoparticle delivery system to produce a synthetic SARS-CoV-2 spike protein that, in effect, turned human bodies into spike protein manufacturing plants.82 The synthetic mRNA and spike protein were supposed to leave the body within a few days or weeks but, it turns out that for some individuals, it has been detected in organs and body systems for months and years compromising genetic integrity and harming the brain and immune system.838485

Reported reactions to the COVID shot range from heart and brain inflammation leading to blood clots and strokes to autoimmune and neurological disorders and death.868788 Just like with influenza and Tdap vaccines recommended during pregnancy, the assumption the COVID shot was safe to give to pregnant women became another example of policy preceding the science.8990

It is now a well-known fact that the COVID biological does not prevent infection and transmission of the SARS-CoV-2 virus.91 There have been over 1.6 million COVID shot reactions, injuries and deaths filed with the federal Vaccine Adverse Event Reporting System (VAERS) since early 2021.92 Importantly, independent studies and reviews of evidence have revealed associations between COVID vaccine and heart damage; sudden death; brain and immune system dysfunction; cancer; menstrual abnormalities and reproductive problems, including miscarriage; premature delivery; birth defects and fetal death/stillbirth, among other serious reactions.93949596979899

03

Hepatitis B Vaccine Recommended for Pregnant Women - But Who Is At Greatest Risk for Infection?

The year after the COVID shot was recommended for all pregnant women to be given during any trimester, the next year the recombinant DNA hepatitis B vaccine, which since 1991 had been recommended for all infants within 24 hours of birth, was recommended by the CDC and medical trade organizations for all adults between 19 and 59 years old, including pregnant women.100

By 2024, that hepatitis B shot recommendation for all adults targeted pregnant women and directed doctors to give a hepatitis B shot to a woman during any trimester of pregnancy if she had never gotten a dose of the vaccine.101

Hepatitis B inactivated vaccine was the first genetically engineered virus like particle vaccine,102 with three doses recommended for children and adults,103 although artificial vaccine acquired immunity is not lifelong and weakens over time.104

But why would a healthy woman need to get a hepatitis B shot during pregnancy?

Hepatitis B is a viral infection that once recovered from, provides lifelong natural immunity unless, in a minority of cases, the person fails to clear the virus and becomes chronically infected, which can lead to liver disease and even cancer later in life.105 But the infection is not spread through sneezing, coughing, hugging and kissing, breastfeeding or food and water like many other contagious diseases that can be easily transmitted in public spaces.106

Hepatitis B is spread from one person to another through infected blood, primarily by older teenagers and adults who are injecting drug users, or have a history of sexually transmitted diseases, or multiple sexual partners.107108109 The primary way that newborns get infected with hepatitis B is when the mother giving birth is already infected.110

At the time the CDC instituted the controversial universal day-of-birth hepatitis B vaccination policy with a goal stopping all circulation of the virus in the U.S., there already was a very low rate of hepatitis B infections among the general public, unlike in parts of Asia and Africa where the disease is still prevalent.111

Before your baby is born, you can get a simple blood test to find out if you are hepatitis B negative or positive.112 It is estimated that less than one percent of pregnant women in the U.S. today are chronically infected with hepatitis B and at risk for transmitting the disease to their newborns.113

The hepatitis B vaccine contains ingredients like recombinant proteins and an aluminum adjuvant to provoke the immune system to mount a strong inflammatory response to induce artificial vaccine acquired temporary immunity.114115116 One hepatitis B vaccine manufacturer states that in clinical studies up to 17 percent of injections within hours and days of administration were followed by reports of fatigue and weakness, headache, fever over 100 F, nausea, diarrhea, upper respiratory infection, abdominal pain, dizziness, joint and muscle pain, and swollen lymph glands.117

Hepatitis B vaccine, like all vaccines, stimulates inflammatory responses in the body that can become chronic if inflammation does not resolve. Two Institute of Medicine reports found too few scientific studies published in the medical literature to determine if hepatitis B vaccine does or does not cause more than two dozen life-altering inflammatory brain and immune system disorders reported after hepatitis B vaccinations including:118119

  • lupus
  • Guillain Barre syndrome (GBS)
  • multiple sclerosis
  • optic neuritis
  • encephalitis
  • encephalopathy
  • peripheral neuropathy like Bell’s Palsy
  • diabetes
  • fibromyalgia
  • vasculitis
  • transverse myelitis
  • heart and blood disorders
  • acute or chronic arthropathy, including rheumatoid arthritis; as well as
  • sudden infant death syndrome or SIDS, which is sudden unexplained death of infants under a year old.
04

RSV Vaccine Comes with Warnings for Pregnant Women

In 2023, the RSV vaccine was licensed by the FDA and recommended by the CDC and medical trade organizations for pregnant women during the last trimester of pregnancy between 32 and 36 weeks gestation.120

There are two kinds of RSV vaccines, one called Abrysvo is for adults, including pregnant women,121 and one is for infants to prevent lower respiratory tract disease caused by the respiratory syncytial virus (RSV) in newborns from the day of birth to six months old.122 Abrysvo is manufactured by Pfizer with recombinant proteins expressed in genetically engineered in Chinese Hamster Ovary cell lines. Among the ingredients are tromethamine and tromethamine hydrochloride,123 and polysorbate 80.124

There are two serious adverse events listed under “WARNINGS AND PRECAUTIONS” for at the top of the manufacturer’s product information package insert for Abrysvo. Number one, the vaccine has been associated with an increased risk of Guillain-Barre syndrome, which is inflammation of the peripheral nerves, for 42 days following vaccination. Number two, that there is a potential risk of preterm birth if given before 32 weeks of pregnancy.125

The most commonly reported adverse events in pre-licensure studies were pain at the injection site, muscle pain, joint pain and nausea in between 12 and 40 percent of recipients, but there were also reports of other more serious conditions, including atrial fibrillation, pre-eclampsia and gestational hypertension within 30 days following vaccination. As with many other vaccines, “Abrysvo has not been evaluated for potential to cause carcinogenicity, genotoxicity or impairment of male fertility,” according to Pfizer.126

05

Conclusion

Pregnant women today need to take a long, hard look at the well-advertised but theoretical benefits – but known and unknown risks – before making a decision to get seven vaccines during pregnancy. It is especially important when the U.S. has the worst maternal mortality and infant mortality rates of all developed countries.

In 2024, there were 18 deaths of American women per 100,000 live births – a maternal mortality ratio more than double, sometimes triple, that of other high-income countries127128129 – plus an equally shocking infant mortality rate of over five American infants in 1,000 live births dying before the first year of life, which is the worst infant mortality rate of all developed nations.130131 This unacceptable poor maternal and infant mortality rate has been going on for the past 20 years, with leading causes of maternal mortality being heart disease, severe post-partum bleeding, blood clots, high blood pressure and stroke.132133 while causes of infant mortality are birth defects, prematurity, low birth weight, sudden infant death syndrome, and pregnancy complications.134

Emerging scientific evidence confirms that not only is there a fundamental lack of scientific understanding about how infectious diseases and vaccines stimulate natural or artificial immunity in the body at the cellular and molecular level,135136137138 but there are basic science knowledge gaps about how infections and vaccines cause complications leading to injury and death.139

If you are considering getting vaccinated during pregnancy, remember that vaccines given to women contain adjuvants and other ingredients known to be neurotoxic,140141 which have not been thoroughly evaluated for genotoxic,142 or adventitious agent contamination effects,143 or for stimulation of intrauterine inflammation in the pregnant woman144 or her fetus that could cause miscarriage145 or brain injury, or otherwise damage the health of the baby after birth.

For example, there have been two signals, one for miscarriage146 and one for chorioamnionitis147 associated with influenza and pertussis containing vaccines given to pregnant women.

Of special concern is evidence published in the medical literature that chronic inflammation in a pregnant woman or developing fetus frequently leads to poor health outcomes in children, including neurodevelopmental delays.148149150

The fact that vaccination provokes an inflammatory response in the body to stimulate the production of artificial immunity,151 an inflammatory response that can become chronic in some individuals,152153154 should not be ignored.

Before you take a risk, find out what it is. Become informed about the risks and complications of infectious diseases and vaccines before you make a decision about getting vaccinated during pregnancy.

Be curious, ask questions. You have the human right to exercise informed consent to medical risk taking.

If your doctor does not respect your right to autonomy and the freedom to make voluntary decisions about vaccination, find a doctor who will.

It’s your health, your family, your choice.

References
  1. 1Soma-Pilloy P, Catherine NP, Talppanen H et al. Physiological changes in pregnancy. Cardiovasc J Afr 2016; 27(2): 81-94
  2. 2Cleveland Clinic. Fetal Development. Mar. 19, 2024.
  3. 3Hill MA. Fetal Development. Embryology Sept. 22, 2026.
  4. 4Kim JH, Scialli AR. Thalidomide: The tragedy of birth defects and the effective treatment of disease. Toxicol Sci 2011; 122(1)(: 1-6.
  5. 5Cleveland Clinic. Everything You Need to Know About the Lamaze Birthing Method. Sept. 24, 2024.
  6. 6Frori A, Oczyk-Pawilowicz M. Breastfeeding Beyond Six Months: Evidence of Child Health Benefits. Nutrients 2024; 16(22): 389.
  7. 7Flavor365. The Surprising Truth About Baby Formulas in the 1950s. Jan. 16, 2025.
  8. 8Mor G, Cardenas I. The Immune System in Pregnancy: A Unique Complexity. Am J Reprod Immunol. Jun. 2010. 63(6): 425–433.
  9. 9Colamatteo A., Fusco C, Micillo T et al. Immunobiology of pregnancy: from basic science to translational medicine. Trends in Molecular Medicine 2023; 29(9): 711-725.
  10. 10Alippe Y, Hatterschide J et al. Innate immune responses to pathogens and the maternal-fetal interface. Nat Rev Immunol 2025; 25: 869-894.
  11. 11Duke-NUS Medical School. Fetal defense: Study reveals early immune protection in the womb. Science Daily Dec. 11, 2025.
  12. 12CDC. Pregnancy and Vaccination: Guidelines for Vaccinating Pregnant Women. Aug. 22, 2025.
  13. 13Santilli V, Sgruletti M, Costagliola G et al. Maternal Immunization: Current Evidence, Progress and Challenges. Vaccines 2025; 13(5).
  14. 14Centers for Disease Control (CDC). Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR July 28, 2006; 55(RR10): 1-42.
  15. 15CDC. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged Under 12 Months – ACIP, 2011. MMWR Oct. 21, 2011; 60(41): 1424-1426.
  16. 16CDC. Update Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women – Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Feb. 23, 2013. 62(07): 133-135.
  17. 17American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice. Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. June 2013.
  18. 18Long SS. CDC recommends Tdap during each pregnancy. AAP News Feb. 1, 2013; 34(2): 8.
  19. 19Torrey T. Understanding Standard of Care for Patients. verywellhealth May 7, 2026.
  20. 20FDA. Vaccines Licensed for Use in the United States. Oct. 8, 2026.
  21. 21CDC. Vaccine Storage and Handling. Where to Find Current Product-Specific Storage and Handling Guidance: FDA-Approved Vaccines. July 14, 2026.
  22. 22Christian LM, Iams JD, Porter K, Glaser R. Inflammatory Responses to Trivalent Influenza Virus Vaccine Among Pregnant Women. Vaccine 2011; 29(48): 8982-8987.
  23. 23Gruber MF. Maternal Immunization: US FDA Regulatory Considerations. (Abstract). Vaccine 2003; 21(24): 3487-3491.
  24. 24CDC. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008; 57:1-51
  25. 25CDC. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged Under 12 Months – ACIP, 2011. Safety of Tdap Vaccine In Pregnant Women. MMWR Oct. 21, 2011; 60(41): 1424-1426.
  26. 26Drugs.com. FDA Pregnancy Categories and FDA Pregnancy Risk Categories Prior to 2015. September 2026.
  27. 27Wilcox CR, Jones CE. Beyond Passive Immunity: Is There Priming of the Fetal Immune System Following Vaccination in Pregnancy and What Are the Potential Clinical Implications? Front Immunol 2018; 9(1548).
  28. 28Saul N, Wang K et al. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-controlled study. Vaccine 2018; 36: 1887-1892.
  29. 29Institute of Medicine Committee to Review Adverse Effects of Vaccines. Adverse Effects of Vaccines: Evidence and Causality: Evaluating Biological Mechanisms of Adverse Events. (p. 57-102), Increased Susceptibility (p. 82). Washington, DC: The National Academies Press 2012.
  30. 30Sanofi Pasteur. Highlights of Prescribing Information for Fluzone Quadrivalent (Influenza Vaccine). Initial US Approval 2013. Revised 2020.
  31. 31GlaxoSmithKline Biologicals. Highlights of Prescribing Information for FLUARIX (Influenza Vaccine). Initial US Approval 2005. Revised 7/2026.
  32. 32Sequiris, Inc. Highlights of Prescribing Information for Flucelvax (Influenza Vaccine). Initial US Approval 2012. Revised 7/2026.
  33. 33Sanofi Vaccines U.S., Inc. Highlights of Prescribing Information for Adacel (Tetanus Toxoid, Reduced Diphtheria and Acellular Pertussis Vaccine Adsorbed). Initial U.S. Approval 2005. Revised 8/2026.
  34. 34GlaxoSmithKline Biologicals. Highlights of Prescribing Information for Boostrix (Tetanus Toxoid, Reduced Diphtheria and Acellular Pertussis Vaccine Adsorbed.). Initial US Approval 2005. Revised 9/2026.
  35. 35Kataoka M, Ochiai M et al. A need for careful evaluation of endotoxin contents in acellular pertussis-based combination vaccines. Biologicals 2012; 40(1): 49-54
  36. 36Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, et al. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Clin Infect Dis 2015; 61:1637–44.
  37. 37Feunou PF, Mielcarek N, Locht C. Reciprocal interference of maternal and infant immunization in protection against pertussis. Vaccine 2016; 34(8): 1062-1069.
  38. 38Orije MRP, Maertens K, Corbiere V et al. The effect of maternal antibodies on the cellular immune response after infant vaccination. Vaccine 2020; 38(1): 20-28.
  39. 39Tomlejenovic L, Shaw CA. Aluminum Vaccine Adjuvants: Are They Safe? Current Medicinal Chemistry 2011; 19(17): 2630-2637.
  40. 40Elce D, Celik A. Genotoxicity of thimerosal in cultured human lymphocytes with and without metabolic activation sister chromatid exchange analysis proliferation index and mitotic index. Toxicology in Vitro June 2008; 22(4): 927-934.
  41. 41Duong A, Steinmaus C, McHale CM et al. Reproductive and developmental toxicity of formaldehyde: A systematic review. In: Mutation Research/Reviews in Mutation Research 2011; 728(3): 118-138.
  42. 42Raines K. Formaldehyde: A Poison and Carcinogen. The Vaccine Reaction Nov. 15, 2025.
  43. 43Speit G, Neuss S, Schutz P et al. The genotoxic potential of gluteraldehyde in mammalian cells in vitro in comparison with formaldehyde. In: Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2008; 649: 146-154.
  44. 44Akunduz MC, Cavuscoglu K, Yacin E. The Potential Risk Assessment of Phenoxyethanol with a Versatile Model System. Sci Rep 2020; 10: 1209.
  45. 45Sun H, Yang R, Wang J et al. Component-based biocompatibility and safety evaluation of polysorbate 80. RSC Advances 2017; 7(25).
  46. 46Parpia R. Polysorbate 80: A Risky Vaccine Ingredient. The Vaccine Reaction Jan. 7, 2016.
  47. 47Haltli B, McQuillan K et al. Next-generation TritonX-100 replacements for pharmaceutical bioprocessing. Croda Pharma November 2024.
  48. 48Drugs.com. Hydrocortisone (injection). Dec. 24, 2025.
  49. 49Suarez-Rivero JM, Pastor-Maldanado CJ, Povea-Cabello S et al. Mitochondria and Antibiotics: For Good or for Evil? Biomolecules 2021; 11(7): 1050.
  50. 50Torabian P. Antibiotics can trigger bacteria to release bubbles of inflammation tinder, making it harder to treat infection. The Conversation Apr. 14, 2026.
  51. 51Zhou L, Li X, Chen J et al. Screening of Low-Tumorigenic MDCK Cells for Potential Influenza Vaccine Substrates and Transcriptomic Analyses. Int J Med Sci 2026; 27(9).
  52. 52Schmidt CW. Uncertain Inheritance: Transgenerational Effects of Environmental Exposures. Environmental Health Perspectives October 2013;12(10).
  53. 53Klibaner-Schiff E, Simonin EM, Akdis CA et al. Environmental exposures influence multigenerational epigenetic transmission. Clin Epigenetics 2024; 16: 145.
  54. 54Cai X, Hutt KJ, Winship Al et al. Safeguard the development of offspring: the role of genetic integrity of the maternal germline. Endocrine Reviews July 22, 2026.
  55. 55Regan AK. The Safety of Maternal Vaccination. Hum Vaccin Immunother 2016; 12(12): 3132-3136.
  56. 56Roberts JN, Gruber MF. Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy. Vaccine 2015; 33(8): 966-972,
  57. 57Zeteyeva YA, Moro PL, Tepper HK et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid and acelullar pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012; 207(1).
  58. 58Mak TK, Mangtani P, Leese J et al. Influenza vaccination during pregnancy: current evidence and selected national policies. The Lancet 2008; 8(1): 44-52.
  59. 59Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359: 1555-1564.
  60. 60CDC. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged Under 12 Months – ACIP, 2011. Safety of Tdap in Pregnant Women. MMWR Oct. 21, 2011; 60(41): 1424-1426.
  61. 61Health Resources Services Administration. Vaccine Injury Compensation Program Data and Statistics: Petitions Filed, Compensated and Dismissed, by Alleged Vaccine, Since the Beginning of VICP, 10/01/1988 through.

    09/01/2026. Updated Sept. 21, 2026.

  62. 62Pellegrino P, Carnovale C, Perrone V et al. Acute Disseminated Encephalomelitis Onset: Evaluation Based on Vaccine Adverse Events Reporting Systems. PLOS One October 2013; 8(10
  63. 63Fisher BL. If Vaccines Injure Pregnant Women or Their Unborn Babies, What Will the Vaccine Court Do? Public Comment for Health Resources Services Administration Sept. 17, 2018.
  64. 64CDC. Past Seasons’ Influenza Vaccine Effectiveness. Mar. 16, 2026.
  65. 65Ward JI, Cherry JD, Chang SJ et al. Bordetella Pertussis Infections in Vaccinated and Unvaccinated Adolescents and Adults, as Assessed in a National Prospective Randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis 2006; 43(2).
  66. 66Fisher BL. Pertussis Microbe Outsmarts the Vaccines as Experts Argue About Why. National Vaccine Information Center Mar. 27, 2016.
  67. 67Gill CH, Gunning CE, MacLeod W et al. Asymptomatic Bordetella pertussis infections in young African infants and their mothers identified within a longitudinal cohort. medRxiv (Preprint) Nov. 19, 2020.
  68. 68Wang B, Zhang S, Liu J. Resurgence of pertussis: Epidemiological trends, contributing factors, challenges, and recommendations for vaccination and surveillance. Human Vaccines & Immunotherapeutics 2025; 21(1).
  69. 69Fisher BL. Coronavirus Vaccine on Fast Track as WHO Declares Global Public Health Emergency. National Vaccine Information Center Feb. 5, 2020.
  70. 70Petri W. COVID-19 vaccines were developed in record time – but are these game-changers safe? The Conversation Nov. 20, 2020
  71. 71Doxzen K, Prichep E. mRNA vaccines – here’s everything you need to know. World Economic Forum July 1, 2021.
  72. 72Doshi P. COVID-19 vaccines: In the rush for regulatory approval, do we need more data? BMJ 2021; 373.
  73. 73Guzman J. CDC reverses statement by director that vaccinated people are no longer contagious. The Hill Apr. 2, 2021.
  74. 74Gander K. Did Joe Biden Spread Misinformation on COVID Vaccine? Newsweek July 22, 2021.
  75. 75Swan DA, Bracis C, Janes H et al. COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact. Scientific Reports 2021; 11(15531).
  76. 76Kons KM, Wood ML, Peck KC et al. Exclusion of Reproductive-aged Women in COVID-19 Vaccination and Clinical Trials. Women’s Health Affairs 2022; 32(6): 557-563.
  77. 77CDC. COVID-19 Vaccines Whie Pregnant or Breastfeeding. June 9, 2021.
  78. 78CDC. New CDC Data: COVID-19 Vaccination Safe for Pregnant People. Aug. 11, 2021.
  79. 79Dunleavy K. While Moderna moves off COVID, Spikevax posts market-share gains on Pfizer rival. Fierce Phama Feb. 22, 2024.
  80. 80Fisher BL. COVID-19 and COVID-19 Vaccines: What Mothers Should Know. National Vaccine Information Center Mar. 11, 2022.
  81. 81Administration of Joseph R. Biden, Jr. Executive Order 14043 – Requiring Coronavirus Disease 2019 Vaccination for Federal Employees. Sept. 9, 2021.
  82. 82Doxzen K, Prichep E. mRNA vaccines – here’s everything you need to know. World Economic Forum July 1, 2021.
  83. 83Boros LG, Kyriokopoulas AM, Borgna C et al. Long‐lasting, biochemically modified mRNA, and its frameshifted recombinant spike proteins in human tissues and circulation after COVID‐19 vaccination. Pharmacol Res Perspect 2024; 12(3).
  84. 84Hulscher N, Schmidt V, Morz M et al. Persistence of Vaccine mRNA, Plasmid DNA, Spike Protein, and Genomic Dysregulation Over 3.5 Years Post-COVID-19 mRNA Vaccination. Zenodo Feb. 2, 2026.
  85. 85Selem E, Raszek M et al. The persistence of COVID-19 vaccine artifacts in bodily fluids: a systematic review. Future J Pharmaceutical Sciences 2026; 12(16).
  86. 86Eslait-Olaciregui S, Llinas-Caballero K, Patino-Manjarres D et al. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature. Ther Adv Drug Saf 2023; 14: 1-18.
  87. 87Boretti A. mRNA vaccine boosters and impaired immune system response in immune compromised individuals: a narrative review. Clin Exp Med 2024; 24(1).
  88. 88Hulscher B, Hodkinson R, Makis W, McCullough PA. Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis. ESC Heart Fail 2024; 12(5): 3212-3225.
  89. 89Trougakos IP, Terpos E, Alexopoulos H et al. Adverse Effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends Mol Med 2023;
  90. 90Catanzaro JA, Hulscher N, MuCullough PA. mRNA Vaccine Shedding, Internal Transcriptional Dissemination and Potential Human to Human Transfer. Zenodo Oct. 26, 2026.
  91. 91Goodwin M. COVID-19 vaccine: Does it stop people getting the disease? Medical News Today Mar. 6, 2023.
  92. 92MedAlerts. Search the VAERS Database: COVID-19 and COVID-19 Bivalent Vaccines. Sept. 25. 2020.
  93. 93Thorp JA, Rogers C, Deskevich MP et al. Increased risk of fetal loss after COVID-19 vaccination. Human Reproduction 2023; 38(2): 2536.
  94. 94Thorp JA, Rogers C, Deskevich MP. COVID-19 Vaccines: The Impact on Pregnancy Outcomes and Menstrual Function. American College of Physicians and Surgeons 2023; 28(1).
  95. 95Pokanen L, Nieminen T, Kovaja P et al. COVID-19 vaccination as a rare etiology for cause of death after medicolegal autopsy. A Finnish national study. Vaccine:X 2025; 24.
  96. 96Kuperwassert C, El-Deiry WS. COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms. Oncotarget 2026; 17:1-29.
  97. 97Tohi W. Oncologist testifies before Senate: COVID mRNA vaccines may trigger cancer replapses. Vaccines.News June 13, 2026.
  98. 98Sharma AJ, Reefhus J, Zauche LH et al. COVID-19 Vaccination During Pregnancy and Birth Defects: Results From the CDC COVID-19 Vaccine Pregnancy Registry, United States 2021–2022. Birth Defects Research 2025; 117(5).
  99. 99Fisher BL, Pebsworth V. Public comment submitted to the FDA on 2025-2026 formulation for COVID-19 vaccine for use in the United States. Pgs. 11-13 with references. National Vaccine Information Center May 23, 2025.
  100. 100CDC. Universal hepatitis B vaccination in adults aged 19–59 years: updated recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Apr. 1, 2022;71:477–83.
  101. 101CDC. Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19–59 Years — United States. MMWR Dec. 5, 2024; 73(48);1106.
  102. 102Bucci N. First recombinant DNA vaccine for HBV. Nature Portfolio Sept. 28, 2020.
  103. 103CDC. Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Nov. 22, 1991; 40 (RR-13): 1-19.
  104. 104Mahmood S, Shah KU, Khan TM. Immune Persistence After Infant Hepatitis-B Vaccination: A Systematic Review and Meta-Analysis. Scientific Reports 2018; 8.
  105. 105Fattovich G. Natural history of hepatitis B. J Hepatol 2003; 39(1): 50-58.
  106. 106Mayo Clinic. Hepatitis B. Jan. 14, 2026.
  107. 107Shing JZ, Ly KN, Xing K et al. Prevalence of Hepatitis B Virus Infection Among US Adults Aged 20–59 Years With a History of Injection Drug Use: National Health and Nutrition Examination Survey, 2001–2016. Clin Infect Dis 2020; 70(12): 2619-2627.
  108. 108Hepatitis B Foundation. LGBTQ+ Risk Factors and Hepatitis B. July 1, 2020,
  109. 109Marseille E, Harris AM, Horvath H et al. Hepatitis B prevalence associated with sexually transmitted infections: A systematic review and meta-analysis. Sex Health 2021; 18(3): 269-279.
  110. 110CDC. Clinical Overview of Hepatitis B. Aug. 29, 2025.
  111. 111Statistica Research Department. Number of. new hepatitis B infections worldwide in 2022, by World Health Organization (WHO) region. June 16, 2025
  112. 112CDC. Clinical Testing and Diagnosis for Hepatitis B. Aug. 14, 2026.
  113. 113Walker TY, Smith EA, Fenlon H et al. Characteristics of Pregnant Women With Hepatitis B Virus Infection in 5 US Public Health Jurisdictions, 2008-2012. Public Health Rep 2016; 13(5): 685-694.
  114. 114Vahdat MM, Hemmati F, Ghorbani A et al. Hepatitis B core-based virus-like particles: A platform for vaccine development in plants. Biotechnology Reports 2021; 29.
  115. 115Exley C. An aluminum adjuvant in a vaccine is an acute exposure to aluminum. J Trace Elements Med Biol 2020; 57: 57-59.
  116. 116Igbokwe IO, Igwenagu E, Igbokwe NA. Aluminum toxicosis: a review of toxic actions and effects. Interdiscip Toxicol 2020.
  117. 117Merck & Co. Highlights of Prescribing Information for RECOMBIVAX HB Hepatitis B Vaccine (Recombinant). Initial U.S. Approval: 1986.
  118. 118Institute of Medicine Vaccine Safety Committee. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Hepatitis B Vaccines. National Academy Press 1994
  119. 119Institute of Medicine Committee to Review Adverse Effects of Vaccines. Adverse Effects of Vaccines: Evidence and Causality. Hepatitis B Vaccine. The National Academies Press 2012.
  120. 120US Food and Drug Administration. FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants. Aug. 21, 2023.
  121. 121U.S. Food and Drug Administration. FDA Approves New Drug to Prevent RSV in Babies and Toddlers. July 17, 2023.
  122. 122CDC. RSV: Immunizations to Protect Infants. Aug. 18, 2025.
  123. 123Medicine.com. Tromethamine. Feb. 25, 2020.
  124. 124Sun H, Yang R, Wang J et al. Component-based biocompatibility and safety evaluation of polysorbate 80. RSC Advances 2017; 7(25).
  125. 125Pfizer, Inc. Highlights for Prescribing Information for ABRYSVO (Respiratory Synctial Virus Vaccine). Initial US Approval: 2023.
  126. 126Ibid.
  127. 127CDC. Maternal Mortality Rates in the United States, 2024. National Center for Health Statistics Mar. 9, 2026.
  128. 128Douthard RA, Martin IK, Chapple-McGruder T et al. U.S. Maternal Mortality Within a Global Context: Historical Trends, Current State and Future Directions. J Womens Health 2021; 30(12): 168-177.
  129. 129Tanne JH. US maternal mortality is far higher than that of other rich nations, study reports. BMJ 2024; 385.
  130. 130CDC. Infant Mortality in the United States: Provisional Data From the 2024 Period Linked Birth/Infant Death Files. National Vital Statistics System Jan. 22, 2026.
  131. 131Kappes W. US Child Mortality Outpaces Other High-Income Nations, Study Shows. The Bump Aug. 20, 2025.
  132. 132Collier AY, Molina RL. Maternal Mortality in the United States: Updates on Trends, Causes and Solutions. Neoreviews 2019; 20(10).
  133. 133CDC. Data from the Pregnancy Mortality Surveillance System: Causes of pregnancy-related deaths. Dec. 18, 2025.
  134. 134CDC. Infant Mortality: Causes of Infant Mortality. Sept. 16, 2024.
  135. 135Furmon D, Davis MM et al. New approaches to understanding the immune response to vaccination and infection. Vaccine 2015; 33(40): 5271-5281.
  136. 136Flaxman A, Ewer KJ. Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man. Vaccines 2018; 6(43).
  137. 137Ma Z, Zuo T et al. A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation. Signal Transduction and Targeted Therapy 2024; 237.
  138. 138Krammer F. The human antibody response to influenza A virus infection and vaccination. Nature Reviews Immunology 2018; 19: 383-397.
  139. 139Herve C, Laupeze B, Del Giudice G et al. The how’s and what’s of vaccine reactogenicity. npj Vaccines 2019; 4(39).
  140. 140Herberts C, Melger B et al. New adjuvanted vaccines in pregnancy: what is known about their safety? Exp Rev Vaccines 2010; 9(12).
  141. 141Kataoka M, Ochiai M et al. A need for careful evaluation of endotoxin contents in acellular pertussis-based combination vaccines. Biologicals 2012; 40(1): 49-54.
  142. 142FDA. Guidance for Industry: S2(R1) Genotoxicty Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. CDER and CBER June 2012,
  143. 143FDA. Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications. CBER February 2010.
  144. 144Romero R, Chaemsaithong P et al. Clinical chorioamnionitis at term V: umbilical cord plastma cytokine profile in the context of a systemic maternal inflammation response. J Perinat Med 2016; 44(1): 53-76.
  145. 145Donahue JG, Kieke BA et al. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12. Vaccine 2017; 35(40): 5314-5322.
  146. 146Ibid.
  147. 147Kharbanda EO, Vazquez-Benitez G et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA 2014; 312(18): 1897-1904.
  148. 148Tilley SK, Joseph RM et al. Genomic markers of prenatal intrauterine inflammation in umbilical cord tissue predict later life neurological outcomes. PLOS One 2017; 12(5).
  149. 149Harvey L, Boksa P. Prenatal and postnatal animal models of immune activation: Relevance to a range of neurodevelopmental disorders. Dev Neurobiol 2012; 72(1): 1335-1348.
  150. 150Brown AG, Tulina NM et al. Exposure to intrauterine inflammation alters metabolomics profiles in the amniotic fluid, fetal and neonatal brain in the mouse. PLOS One Oct. 19, 2017
  151. 151Clem AS. Fundamentals of Vaccine Immunology. J Glob Infect Dis 2011; 3(1): 73-78.
  152. 152Zhuang CL, Lin ZJ, Bi ZF et al. Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response. Emerging Microbes & Infections 2020; 10: 365-375.
  153. 153Chen L, Deng H, Cui H et al. Inflammatory responses and inflammation-associated disease in organs. Oncotarget 2017; 9(6): 7204-7218.
  154. 154Institute of Medicine Committee to Review Adverse Effects of Vaccines. Adverse Effects of Vaccines: Evidence and Causality: Evaluating Biological Mechanisms of Adverse Events. (p. 57-102), Increased Susceptibility (p. 82). Washington, DC: The National Academies Press 2012.

Leave a Comment

Your email address will not be published. Required fields are marked *

Select disease / vaccine